APA (7th ed.) Citation

Lin, Q., Qiu, M., Wei, X., xiang, Z., Zhou, Z., Ji, I., . . . Yu, H. (2023). Genetic variants of SOS2, MAP2K1 and RASGRF2 in the RAS pathway genes predict survival of HBV-related hepatocellular carcinoma patients. Archives of Toxicology, 97(6), 1599-1611. https://doi.org/10.1007/s00204-023-03469-5

Chicago Style (17th ed.) Citation

Lin, Qiuling, et al. "Genetic Variants of SOS2, MAP2K1 and RASGRF2 in the RAS Pathway Genes Predict Survival of HBV-related Hepatocellular Carcinoma Patients." Archives of Toxicology 97, no. 6 (2023): 1599-1611. https://doi.org/10.1007/s00204-023-03469-5.

MLA (9th ed.) Citation

Lin, Qiuling, et al. "Genetic Variants of SOS2, MAP2K1 and RASGRF2 in the RAS Pathway Genes Predict Survival of HBV-related Hepatocellular Carcinoma Patients." Archives of Toxicology, vol. 97, no. 6, 2023, pp. 1599-1611, https://doi.org/10.1007/s00204-023-03469-5.